Alembic Pharma to buybackΒ up to 1,02,50,000 equity shares of the company. The company proposes to buybackΒ 1,02,50,000 fully paid up equity shares of the company of...
Alembic Pharmaceuticals Ltd (APL) has entered into a joint venture with Orbicular Pharmaceutical Technologies and Dr M S Mohan for developing, manufacturing and commercializing dermatology...